Greenwich LifeSciences, Inc.
GLSI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001799788
In the last 90 days, Greenwich LifeSciences, Inc. insiders filed 3 open-market purchases and 0 sales; 57 institutions reported holding it in 13F filings for Q2 2026, worth $39.6M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Greenwich LifeSciences, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −13 vs. Q2 2022
- Shares held
- 792.9K
- −239.3K (−23.2%) vs. Q2 2022
- Total value
- $7.21M
- −$1.53M (−17.5%) vs. Q2 2022
- New holders
- 2
- 4 more added
- Sold out
- 15
- 9 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GLSI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 57 | $39.6M |
| Q1 2026 | 64 | $41.1M |
| Q4 2025 | 50 | $27.9M |
| Q3 2025 | 51 | $12.1M |
| Q2 2025 | 51 | $11.2M |
| Q1 2025 | 46 | $11.1M |
| Q4 2024 | 42 | $13.3M |
| Q3 2024 | 39 | $16.4M |
| Q2 2024 | 34 | $17.6M |
| Q1 2024 | 31 | $12.9M |
| Q4 2023 | 27 | $5.64M |
| Q3 2023 | 24 | $4.75M |
| Q2 2023 | 23 | $6.06M |
| Q1 2023 | 28 | $11.4M |
| Q4 2022 | 22 | $10.2M |
| Q3 2022 | 21 | $7.21M |
| Q2 2022 | 34 | $8.74M |
| Q1 2022 | 34 | $18.3M |
| Q4 2021 | 35 | $19.4M |
| Q3 2021 | 36 | $31.9M |
| Q2 2021 | 30 | $36.4M |
| Q1 2021 | 19 | $8.90M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Greenwich LifeSciences, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 344,436 | $3.13M | 0.00% | −9,800−2.8% | Reduced |
| Marshall Wace, LLP | 76,923 | $702.0K | 0.00% | −12,813−14.3% | Reduced |
| Ameriprise Financial Inc | 61,701 | $561.0K | 0.00% | +19,520+46.3% | Added |
| Millennium Management LLC | 59,813 | $544.0K | 0.00% | −30,479−33.8% | Reduced |
| Renaissance Technologies LLC | 56,701 | $516.0K | 0.00% | −48,458−46.1% | Reduced |
| BlackRock Inc. | 50,811 | $462.0K | 0.00% | −240−0.5% | Reduced |
| Geode Capital Management, LLC | 42,259 | $384.0K | 0.00% | +1,280+3.1% | Added |
| Morgan Stanley | 35,235 | $321.0K | 0.00% | −37,955−51.9% | Reduced |
| Pura Vida Investments, LLC | 19,667 | $179.0K | 0.03% | +19,667 | New |
| Bank of America Corp | 16,061 | $146.0K | 0.00% | +5,416+50.9% | Added |
| State Street Corp | 13,002 | $118.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 12,029 | $109.0K | 0.00% | +12,029 | New |
| UBS Group AG | 1,809 | $17.0K | 0.00% | +939+107.9% | Added |
| Founders Capital Management | 1,000 | $9.00K | 0.01% | 00.0% | Unchanged |
| Royal Bank of Canada | 701 | $6.00K | 0.00% | −699−49.9% | Reduced |
| Newbridge Financial Services Group, Inc. | 500 | $5.00K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 93 | $1.00K | 0.00% | −48−34.0% | Reduced |
| JPMorgan Chase & Co | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 23 | $0 | 0.00% | −4−14.8% | Reduced |
| North Star Investment Management Corp. | 51 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −23,440−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −21,431−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −17,800−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −17,657−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −17,631−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,332−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −12,322−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −10,656−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −1,291−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −24−100.0% | Sold out |